APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioids Drug

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Selected research

Market Analysis & Forecast

Global Opioids Drug Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchOpioids Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioids Drug Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Opioids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioids Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioids Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

This report presents an overview of global market for Opioids Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Opioids Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Opioids Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioids Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Opioids Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Opioids Drug sales, projected growth trends, production technology, application and end-user industry.

Opioids Drug Segment by Company

Teva

Purdue Pharma

Mallinckrodt

Amneal Pharma

Collegium

J&J

Endo

Pfizer

INSYS

Mylan

Hikma

Egalet

Opioids Drug Segment by Type

Oxycodone

Hydromorphone

Codeine

Fentanyl

Opioids Drug Segment by Application

Pain Relief

Anesthesia

Others

Opioids Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Opioids Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioids Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Opioids Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oxycodone Major Manufacturers Table 3. Hydromorphone Major Manufacturers Table 4. Codeine Major Manufacturers Table 5. Fentanyl Major Manufacturers Table 6. Global Opioids Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pain Relief Major Manufacturers Table 8. Anesthesia Major Manufacturers Table 9. Others Major Manufacturers Table 10. Opioids Drug Industry Trends Table 11. Opioids Drug Industry Drivers Table 12. Opioids Drug Industry Opportunities and Challenges Table 13. Opioids Drug Industry Restraints Table 14. Global Opioids Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Opioids Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Opioids Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Opioids Drug Revenue Market Share by Region (2021-2026) Table 18. Global Opioids Drug Revenue Market Share by Region (2027-2032) Table 19. Global Opioids Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 20. Global Opioids Drug Sales by Region (2021-2026) & (M Units) Table 21. Global Opioids Drug Sales by Region (2027-2032) & (M Units) Table 22. Global Opioids Drug Sales Market Share by Region (2021-2026) Table 23. Global Opioids Drug Sales Market Share by Region (2027-2032) Table 24. Global Opioids Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Opioids Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Opioids Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Opioids Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Opioids Drug Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 29. Global Opioids Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Opioids Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Opioids Drug Manufacturers, Product Type & Application Table 32. Global Opioids Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Opioids Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Opioids Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Opioids Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Opioids Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Opioids Drug Revenue Market Share by Type (2021-2026) Table 39. Global Opioids Drug Revenue Market Share by Type (2027-2032) Table 40. Global Opioids Drug Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 41. Global Opioids Drug Sales by Type (2021-2026) & (M Units) Table 42. Global Opioids Drug Sales by Type (2027-2032) & (M Units) Table 43. Global Opioids Drug Sales Market Share by Type (2021-2026) Table 44. Global Opioids Drug Sales Market Share by Type (2027-2032) Table 45. Global Opioids Drug Price by Type (2021-2026) & (USD/Unit) Table 46. Global Opioids Drug Price by Type (2027-2032) & (USD/Unit) Table 47. Global Opioids Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Opioids Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Opioids Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Opioids Drug Revenue Market Share by Application (2021-2026) Table 51. Global Opioids Drug Revenue Market Share by Application (2027-2032) Table 52. Global Opioids Drug Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 53. Global Opioids Drug Sales by Application (2021-2026) & (M Units) Table 54. Global Opioids Drug Sales by Application (2027-2032) & (M Units) Table 55. Global Opioids Drug Sales Market Share by Application (2021-2026) Table 56. Global Opioids Drug Sales Market Share by Application (2027-2032) Table 57. Global Opioids Drug Price by Application (2021-2026) & (USD/Unit) Table 58. Global Opioids Drug Price by Application (2027-2032) & (USD/Unit) Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 62. Teva Opioids Drug Product Portfolio Table 63. Teva Recent Development Table 64. Purdue Pharma Company Information Table 65. Purdue Pharma Business Overview Table 66. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Purdue Pharma Opioids Drug Product Portfolio Table 68. Purdue Pharma Recent Development Table 69. Mallinckrodt Company Information Table 70. Mallinckrodt Business Overview Table 71. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Mallinckrodt Opioids Drug Product Portfolio Table 73. Mallinckrodt Recent Development Table 74. Amneal Pharma Company Information Table 75. Amneal Pharma Business Overview Table 76. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Amneal Pharma Opioids Drug Product Portfolio Table 78. Amneal Pharma Recent Development Table 79. Collegium Company Information Table 80. Collegium Business Overview Table 81. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Collegium Opioids Drug Product Portfolio Table 83. Collegium Recent Development Table 84. J&J Company Information Table 85. J&J Business Overview Table 86. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. J&J Opioids Drug Product Portfolio Table 88. J&J Recent Development Table 89. Endo Company Information Table 90. Endo Business Overview Table 91. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Endo Opioids Drug Product Portfolio Table 93. Endo Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Opioids Drug Product Portfolio Table 98. Pfizer Recent Development Table 99. INSYS Company Information Table 100. INSYS Business Overview Table 101. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. INSYS Opioids Drug Product Portfolio Table 103. INSYS Recent Development Table 104. Mylan Company Information Table 105. Mylan Business Overview Table 106. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Mylan Opioids Drug Product Portfolio Table 108. Mylan Recent Development Table 109. Hikma Company Information Table 110. Hikma Business Overview Table 111. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Hikma Opioids Drug Product Portfolio Table 113. Hikma Recent Development Table 114. Egalet Company Information Table 115. Egalet Business Overview Table 116. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Egalet Opioids Drug Product Portfolio Table 118. Egalet Recent Development Table 119. North America Opioids Drug Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Opioids Drug Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Opioids Drug Sales by Type (2021-2026) & (M Units) Table 122. North America Opioids Drug Sales by Type (2027-2032) & (M Units) Table 123. North America Opioids Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 124. North America Opioids Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 125. North America Opioids Drug Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Opioids Drug Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Opioids Drug Sales by Application (2021-2026) & (M Units) Table 128. North America Opioids Drug Sales by Application (2027-2032) & (M Units) Table 129. North America Opioids Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 130. North America Opioids Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 131. North America Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Opioids Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. North America Opioids Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. North America Opioids Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 135. North America Opioids Drug Sales by Country (2021-2026) & (M Units) Table 136. North America Opioids Drug Sales by Country (2027-2032) & (M Units) Table 137. North America Opioids Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 138. North America Opioids Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 139. United States Opioids Drug Revenue (2021-2032) & (US$ Million) Table 140. Canada Opioids Drug Revenue (2021-2032) & (US$ Million) Table 141. Mexico Opioids Drug Revenue (2021-2032) & (US$ Million) Table 142. Europe Opioids Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Opioids Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Opioids Drug Sales by Type (2021-2026) & (M Units) Table 145. Europe Opioids Drug Sales by Type (2027-2032) & (M Units) Table 146. Europe Opioids Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 147. Europe Opioids Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 148. Europe Opioids Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe Opioids Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe Opioids Drug Sales by Application (2021-2026) & (M Units) Table 151. Europe Opioids Drug Sales by Application (2027-2032) & (M Units) Table 152. Europe Opioids Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 153. Europe Opioids Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 154. Europe Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Opioids Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Europe Opioids Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Europe Opioids Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 158. Europe Opioids Drug Sales by Country (2021-2026) & (M Units) Table 159. Europe Opioids Drug Sales by Country (2027-2032) & (M Units) Table 160. Europe Opioids Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 161. Europe Opioids Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 162. Germany Opioids Drug Revenue (2021-2032) & (US$ Million) Table 163. France Opioids Drug Revenue (2021-2032) & (US$ Million) Table 164. U.K. Opioids Drug Revenue (2021-2032) & (US$ Million) Table 165. Italy Opioids Drug Revenue (2021-2032) & (US$ Million) Table 166. Russia Opioids Drug Revenue (2021-2032) & (US$ Million) Table 167. Spain Opioids Drug Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Opioids Drug Revenue (2021-2032) & (US$ Million) Table 169. Switzerland Opioids Drug Revenue (2021-2032) & (US$ Million) Table 170. Sweden Opioids Drug Revenue (2021-2032) & (US$ Million) Table 171. Poland Opioids Drug Revenue (2021-2032) & (US$ Million) Table 172. China Opioids Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. China Opioids Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. China Opioids Drug Sales by Type (2021-2026) & (M Units) Table 175. China Opioids Drug Sales by Type (2027-2032) & (M Units) Table 176. China Opioids Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 177. China Opioids Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 178. China Opioids Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. China Opioids Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. China Opioids Drug Sales by Application (2021-2026) & (M Units) Table 181. China Opioids Drug Sales by Application (2027-2032) & (M Units) Table 182. China Opioids Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 183. China Opioids Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 184. Asia Opioids Drug Revenue by Type (2021-2026) & (US$ Million) Table 185. Asia Opioids Drug Revenue by Type (2027-2032) & (US$ Million) Table 186. Asia Opioids Drug Sales by Type (2021-2026) & (M Units) Table 187. Asia Opioids Drug Sales by Type (2027-2032) & (M Units) Table 188. Asia Opioids Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 189. Asia Opioids Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 190. Asia Opioids Drug Revenue by Application (2021-2026) & (US$ Million) Table 191. Asia Opioids Drug Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia Opioids Drug Sales by Application (2021-2026) & (M Units) Table 193. Asia Opioids Drug Sales by Application (2027-2032) & (M Units) Table 194. Asia Opioids Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 195. Asia Opioids Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 196. Asia Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Asia Opioids Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Asia Opioids Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Asia Opioids Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 200. Asia Opioids Drug Sales by Country (2021-2026) & (M Units) Table 201. Asia Opioids Drug Sales by Country (2027-2032) & (M Units) Table 202. Asia Opioids Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 203. Asia Opioids Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 204. Japan Opioids Drug Revenue (2021-2032) & (US$ Million) Table 205. South Korea Opioids Drug Revenue (2021-2032) & (US$ Million) Table 206. India Opioids Drug Revenue (2021-2032) & (US$ Million) Table 207. Australia Opioids Drug Revenue (2021-2032) & (US$ Million) Table 208. Taiwan Opioids Drug Revenue (2021-2032) & (US$ Million) Table 209. Southeast Asia Opioids Drug Revenue (2021-2032) & (US$ Million) Table 210. SAMEA Opioids Drug Revenue by Type (2021-2026) & (US$ Million) Table 211. SAMEA Opioids Drug Revenue by Type (2027-2032) & (US$ Million) Table 212. SAMEA Opioids Drug Sales by Type (2021-2026) & (M Units) Table 213. SAMEA Opioids Drug Sales by Type (2027-2032) & (M Units) Table 214. SAMEA Opioids Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 215. SAMEA Opioids Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 216. SAMEA Opioids Drug Revenue by Application (2021-2026) & (US$ Million) Table 217. SAMEA Opioids Drug Revenue by Application (2027-2032) & (US$ Million) Table 218. SAMEA Opioids Drug Sales by Application (2021-2026) & (M Units) Table 219. SAMEA Opioids Drug Sales by Application (2027-2032) & (M Units) Table 220. SAMEA Opioids Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 221. SAMEA Opioids Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 222. SAMEA Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. SAMEA Opioids Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. SAMEA Opioids Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. SAMEA Opioids Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 226. SAMEA Opioids Drug Sales by Country (2021-2026) & (M Units) Table 227. SAMEA Opioids Drug Sales by Country (2027-2032) & (M Units) Table 228. SAMEA Opioids Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 229. SAMEA Opioids Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 230. Brazil Opioids Drug Revenue (2021-2032) & (US$ Million) Table 231. Argentina Opioids Drug Revenue (2021-2032) & (US$ Million) Table 232. Chile Opioids Drug Revenue (2021-2032) & (US$ Million) Table 233. Colombia Opioids Drug Revenue (2021-2032) & (US$ Million) Table 234. Peru Opioids Drug Revenue (2021-2032) & (US$ Million) Table 235. Saudi Arabia Opioids Drug Revenue (2021-2032) & (US$ Million) Table 236. Israel Opioids Drug Revenue (2021-2032) & (US$ Million) Table 237. UAE Opioids Drug Revenue (2021-2032) & (US$ Million) Table 238. Turkey Opioids Drug Revenue (2021-2032) & (US$ Million) Table 239. Iran Opioids Drug Revenue (2021-2032) & (US$ Million) Table 240. Egypt Opioids Drug Revenue (2021-2032) & (US$ Million) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Opioids Drug Distributors List Table 244. Opioids Drug Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Opioids Drug Image Figure 2. Global Opioids Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioids Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oxycodone Image Figure 5. Hydromorphone Image Figure 6. Codeine Image Figure 7. Fentanyl Image Figure 8. Global Opioids Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Opioids Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pain Relief Image Figure 11. Anesthesia Image Figure 12. Others Image Figure 13. Global Opioids Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Opioids Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Opioids Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Opioids Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Opioids Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Opioids Drug Sales (2021-2032) & (M Units) Figure 19. Global Opioids Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 20. Global Opioids Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Opioids Drug Sales YoY (2021-2032) & (M Units) Figure 22. Europe Opioids Drug Sales YoY (2021-2032) & (M Units) Figure 23. China Opioids Drug Sales YoY (2021-2032) & (M Units) Figure 24. Asia (Excluding China) Opioids Drug Sales YoY (2021-2032) & (M Units) Figure 25. South America, Middle East and Africa Opioids Drug Sales YoY (2021-2032) & (M Units) Figure 26. Global Opioids Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Opioids Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Opioids Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Opioids Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Opioids Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Opioids Drug Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 33. Global Opioids Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Opioids Drug Sales Market Share by Type (2021-2032) Figure 35. Global Opioids Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Opioids Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Opioids Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Opioids Drug Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 39. Global Opioids Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Opioids Drug Sales Market Share by Application (2021-2032) Figure 41. North America Opioids Drug Revenue Share by Type (2021-2032) Figure 42. North America Opioids Drug Sales Share by Type (2021-2032) Figure 43. North America Opioids Drug Revenue Share by Application (2021-2032) Figure 44. North America Opioids Drug Sales Share by Application (2021-2032) Figure 45. North America Opioids Drug Revenue Share by Country (2021-2032) Figure 46. North America Opioids Drug Sales Share by Country (2021-2032) Figure 47. Europe Opioids Drug Revenue Share by Type (2021-2032) Figure 48. Europe Opioids Drug Sales Share by Type (2021-2032) Figure 49. Europe Opioids Drug Revenue Share by Application (2021-2032) Figure 50. Europe Opioids Drug Sales Share by Application (2021-2032) Figure 51. Europe Opioids Drug Revenue Share by Country (2021-2032) Figure 52. Europe Opioids Drug Sales Share by Country (2021-2032) Figure 53. China Opioids Drug Revenue Share by Type (2021-2032) Figure 54. China Opioids Drug Sales Share by Type (2021-2032) Figure 55. China Opioids Drug Revenue Share by Application (2021-2032) Figure 56. China Opioids Drug Sales Share by Application (2021-2032) Figure 57. Asia Opioids Drug Revenue Share by Type (2021-2032) Figure 58. Asia Opioids Drug Sales Share by Type (2021-2032) Figure 59. Asia Opioids Drug Revenue Share by Application (2021-2032) Figure 60. Asia Opioids Drug Sales Share by Application (2021-2032) Figure 61. Asia Opioids Drug Revenue Share by Country (2021-2032) Figure 62. Asia Opioids Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Opioids Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Opioids Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Opioids Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Opioids Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Opioids Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Opioids Drug Sales Share by Country (2021-2032) Figure 69. Opioids Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Opioids Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Oxycodone
  • Hydromorphone
  • Codeine
  • Fentanyl
Applications
  • Pain Relief
  • Anesthesia
  • Others
Companies covered
  • Teva
  • Purdue Pharma
  • Mallinckrodt
  • Amneal Pharma
  • Collegium
  • J&J
  • Endo
  • Pfizer
  • INSYS
  • Mylan
  • Hikma
  • Egalet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Opioids Drug Market by Type
  3. 1.2.1 Global Opioids Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oxycodone
  5. 1.2.3 Hydromorphone
  6. 1.2.4 Codeine
  7. 1.2.5 Fentanyl
  8. 1.3 Opioids Drug Market by Application
  9. 1.3.1 Global Opioids Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pain Relief
  11. 1.3.3 Anesthesia
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Opioids Drug Market Dynamics
  1. 2.1 Opioids Drug Industry Trends
  2. 2.2 Opioids Drug Industry Drivers
  3. 2.3 Opioids Drug Industry Opportunities and Challenges
  4. 2.4 Opioids Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Opioids Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Opioids Drug Revenue by Region
  3. 3.2.1 Global Opioids Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Opioids Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Opioids Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Opioids Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Opioids Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Opioids Drug Sales by Region
  9. 3.4.1 Global Opioids Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Opioids Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Opioids Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Opioids Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Opioids Drug Revenue by Manufacturers
  2. 4.1.1 Global Opioids Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Opioids Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Opioids Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Opioids Drug Sales by Manufacturers
  6. 4.2.1 Global Opioids Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Opioids Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Opioids Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Opioids Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Opioids Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Opioids Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Opioids Drug Manufacturers, Product Type & Application
  13. 4.7 Global Opioids Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Opioids Drug Market CR5 and HHI
  16. 4.8.2 2025 Opioids Drug Tier 1, Tier 2, and Tier 3
5 Opioids Drug Market by Type
  1. 5.1 Global Opioids Drug Revenue by Type
  2. 5.1.1 Global Opioids Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Opioids Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Opioids Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Opioids Drug Sales by Type
  6. 5.2.1 Global Opioids Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioids Drug Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Opioids Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Opioids Drug Price by Type
6 Opioids Drug Market by Application
  1. 6.1 Global Opioids Drug Revenue by Application
  2. 6.1.1 Global Opioids Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Opioids Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Opioids Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Opioids Drug Sales by Application
  6. 6.2.1 Global Opioids Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Opioids Drug Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Opioids Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Opioids Drug Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Opioids Drug Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Purdue Pharma
  8. 7.2.1 Purdue Pharma Company Information
  9. 7.2.2 Purdue Pharma Business Overview
  10. 7.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Purdue Pharma Opioids Drug Product Portfolio
  12. 7.2.5 Purdue Pharma Recent Developments
  13. 7.3 Mallinckrodt
  14. 7.3.1 Mallinckrodt Company Information
  15. 7.3.2 Mallinckrodt Business Overview
  16. 7.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mallinckrodt Opioids Drug Product Portfolio
  18. 7.3.5 Mallinckrodt Recent Developments
  19. 7.4 Amneal Pharma
  20. 7.4.1 Amneal Pharma Company Information
  21. 7.4.2 Amneal Pharma Business Overview
  22. 7.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Amneal Pharma Opioids Drug Product Portfolio
  24. 7.4.5 Amneal Pharma Recent Developments
  25. 7.5 Collegium
  26. 7.5.1 Collegium Company Information
  27. 7.5.2 Collegium Business Overview
  28. 7.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Collegium Opioids Drug Product Portfolio
  30. 7.5.5 Collegium Recent Developments
  31. 7.6 J&J
  32. 7.6.1 J&J Company Information
  33. 7.6.2 J&J Business Overview
  34. 7.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 J&J Opioids Drug Product Portfolio
  36. 7.6.5 J&J Recent Developments
  37. 7.7 Endo
  38. 7.7.1 Endo Company Information
  39. 7.7.2 Endo Business Overview
  40. 7.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Endo Opioids Drug Product Portfolio
  42. 7.7.5 Endo Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Opioids Drug Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 INSYS
  50. 7.9.1 INSYS Company Information
  51. 7.9.2 INSYS Business Overview
  52. 7.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 INSYS Opioids Drug Product Portfolio
  54. 7.9.5 INSYS Recent Developments
  55. 7.10 Mylan
  56. 7.10.1 Mylan Company Information
  57. 7.10.2 Mylan Business Overview
  58. 7.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mylan Opioids Drug Product Portfolio
  60. 7.10.5 Mylan Recent Developments
  61. 7.11 Hikma
  62. 7.11.1 Hikma Company Information
  63. 7.11.2 Hikma Business Overview
  64. 7.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hikma Opioids Drug Product Portfolio
  66. 7.11.5 Hikma Recent Developments
  67. 7.12 Egalet
  68. 7.12.1 Egalet Company Information
  69. 7.12.2 Egalet Business Overview
  70. 7.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Egalet Opioids Drug Product Portfolio
  72. 7.12.5 Egalet Recent Developments
8 North America
  1. 8.1 North America Opioids Drug Market Size by Type
  2. 8.1.1 North America Opioids Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Opioids Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Opioids Drug Price by Type (2021-2032)
  5. 8.2 North America Opioids Drug Market Size by Application
  6. 8.2.1 North America Opioids Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Opioids Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Opioids Drug Price by Application (2021-2032)
  9. 8.3 North America Opioids Drug Market Size by Country
  10. 8.3.1 North America Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Opioids Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Opioids Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Opioids Drug Market Size by Type
  2. 9.1.1 Europe Opioids Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Opioids Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Opioids Drug Price by Type (2021-2032)
  5. 9.2 Europe Opioids Drug Market Size by Application
  6. 9.2.1 Europe Opioids Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Opioids Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Opioids Drug Price by Application (2021-2032)
  9. 9.3 Europe Opioids Drug Market Size by Country
  10. 9.3.1 Europe Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Opioids Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Opioids Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Opioids Drug Market Size by Type
  2. 10.1.1 China Opioids Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Opioids Drug Sales by Type (2021-2032)
  4. 10.1.3 China Opioids Drug Price by Type (2021-2032)
  5. 10.2 China Opioids Drug Market Size by Application
  6. 10.2.1 China Opioids Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Opioids Drug Sales by Application (2021-2032)
  8. 10.2.3 China Opioids Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Opioids Drug Market Size by Type
  2. 11.1.1 Asia Opioids Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Opioids Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Opioids Drug Price by Type (2021-2032)
  5. 11.2 Asia Opioids Drug Market Size by Application
  6. 11.2.1 Asia Opioids Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Opioids Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Opioids Drug Price by Application (2021-2032)
  9. 11.3 Asia Opioids Drug Market Size by Country
  10. 11.3.1 Asia Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Opioids Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Opioids Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Opioids Drug Market Size by Type
  2. 12.1.1 SAMEA Opioids Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Opioids Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Opioids Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Opioids Drug Market Size by Application
  6. 12.2.1 SAMEA Opioids Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Opioids Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Opioids Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Opioids Drug Market Size by Country
  10. 12.3.1 SAMEA Opioids Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Opioids Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Opioids Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Opioids Drug Value Chain Analysis
  2. 13.1.1 Opioids Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Opioids Drug Production Mode & Process
  6. 13.2 Opioids Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Opioids Drug Distributors
  9. 13.2.3 Opioids Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst